The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 3 , Pages 631-640 , September 2008

Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery

  • Michael E. Halkos, MD

      Affiliations

    • Clinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • John D. Puskas, MD

      Affiliations

    • Department of Biostatistics, Rollins School of Public Health, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Omar M. Lattouf, MD, PhD

      Affiliations

    • Clinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Patrick Kilgo, MSc

      Affiliations

    • Department of Biostatistics, Rollins School of Public Health, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Faraz Kerendi, MD

      Affiliations

    • Clinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Howard K. Song, MD, PhD

      Affiliations

    • Division of Cardiothoracic Surgery, Oregon Health and Science University, Portland, Oregon
    • ,
  • Robert A. Guyton, MD

      Affiliations

    • Clinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Vinod H. Thourani, MD

      Affiliations

    • Clinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia
    • Corresponding Author InformationAddress for reprints: Vinod H. Thourani, MD, 550 Peachtree Street, Crawford Long Hospital, 6th Floor, Medical Office Tower, Cardiothoracic Surgery, Atlanta, GA 30308.

Received 8 May 2007 ,Revised 12 January 2008 ,Accepted 7 February 2008.

References 

  1. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation. 1979;59:8–13
  2. Thourani VH, Weintraub WS, Stein B, Gebhart SSP, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcomes after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045–1052
  3. Carson JL, Scholz PM, Chen AY, Petersen ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418–423
  4. Woods SE, Smith JM, Sohail S, Sarah A, Engle A. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery. Chest. 2004;126:1789–1795
  5. Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione R. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk adjusted analysis. J Thorac Cardiovasc Surg. 2006;132:802–810
  6. Calafiore AM, Di Mauro M, Di Giammarco G, Contini M, Vitolla G, Iaco AL, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg. 2003;125:144–154
  7. Kubal C, Srinivasan AK, Grayson AD, Fabri BM, Chalmers JAC. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg. 2005;79:1570–1576
  8. Whang W, Bigger JT. Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from the CABG Patch Trial Database. J Am Coll Cardiol. 2000;36:1166–1172
  9. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002;74:712–719
  10. Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland diabetic project. Semin Thorac Cardiovasc Surg. 2006;18:302–308
  11. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497–1502
  12. Carr JM, Sellke FW, Fey M, Doyle MJ, Krempin JA, de la Torre R, et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg. 2005;80:902–909
  13. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145–150
  14. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–1021
  15. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352–362
  16. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28:S4–S36
  17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  18. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  19. Rubin DB. Inference and missing data. Biometrika. 1976;53:581–592
  20. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation. 1997;96:1761–1769
  21. Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation. 2004;110:41–44
  22. Hirotani T, Kameda T, Kumamoto T, Shirota S, Yamano M. Effects of coronary artery bypass grafting using internal mammary arteries for diabetic patients. J Am Coll Cardiol. 1999;34:532–538
  23. Bradshaw PJ, Jamrozik K, Gilfillan I, Thompson PL. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study. Am Heart J. 2004;147:1047–1053
  24. Lawrie GM, Morris GC, Glaeser DH. Influence of diabetes mellitus on the results of coronary bypass surgery: follow-up of 212 diabetic patients ten to fifteen years after surgery. JAMA. 1986;256:2967–2971
  25. Herlitz J, Wognsen GB, Emanuelsson H, Haglid M, Karlson BW, Karlsson T, et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care. 1996;30:71–75
  26. Salomon NW, Page US, Okies JE, Stephens J, Krause AH, Bigelow JC. Diabetes mellitus and coronary artery bypass: short-term risk and long-term prognosis. J Thorac Cardiovasc Surg. 1983;85:264–271
  27. Clement R, Rousou JA, Engelman RM, Breyer RH. Perioperative morbidity in diabetics requiring coronary artery bypass surgery. Ann Thorac Surg. 1988;46:321–323
  28. Fietsam R, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg. 1991;57:551–557
  29. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA. 2006;295:1688–1697
  30. The ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus Statement on inpatient diabetes and glycemic control. Diabetes Care. 2006;29:1955–1962

 Presented at the 87th Annual Meeting of The American Association for Thoracic Surgery. Washington, DC, May 5–9, 2007.

PII: S0022-5223(08)01094-5

doi: 10.1016/j.jtcvs.2008.02.091

The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 3 , Pages 631-640 , September 2008

Article Tools